RI S0573 | 2023 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 8-0)
Status: Introduced on March 7 2023 - 25% progression, died in committee
Action: 2023-05-09 - Committee recommended measure be held for further study
Pending: Senate Health and Human Services Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 7 2023 - 25% progression, died in committee
Action: 2023-05-09 - Committee recommended measure be held for further study
Pending: Senate Health and Human Services Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name on list.
Title
The Prescription Drug Sales Representative Disclosure Act
Sponsors
Sen. Bridget Valverde [D] | Sen. Joshua Miller [D] | Sen. Valarie Lawson [D] | Sen. Pamela Lauria [D] |
Sen. Alana DiMario [D] | Sen. Louis Dipalma [D] | Sen. Melissa Murray [D] | Sen. Meghan Kallman [D] |
History
Date | Chamber | Action |
---|---|---|
2023-05-09 | Senate | Committee recommended measure be held for further study |
2023-05-05 | Senate | Scheduled for hearing and/or consideration (05/09/2023) |
2023-04-04 | Senate | Committee recommended measure be held for further study |
2023-03-31 | Senate | Scheduled for hearing and/or consideration (04/04/2023) |
2023-03-07 | Senate | Introduced, referred to Senate Health and Human Services |
Rhode Island State Sources
Type | Source |
---|---|
Summary | https://status.rilegislature.gov/ |
Text | https://webserver.rilegislature.gov/BillText23/SenateText23/S0573.pdf |